Suppliers / Công ty Cổ Phần Dược Phẩm Reliv

Công ty Cổ Phần Dược Phẩm Reliv

Vietnam 54 employees Updated 9 July 2026

Công ty Cổ Phần Dược Phẩm Reliv is an API manufacturer based in Vietnam. It appears in 82 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam) and NPRA (MY).

0
active US DMFs
0
valid CEPs
0
registered plants
82
filings across 2 regulators

What they file, and where

Molecule Regulators Docs
Ciprofloxacin DAV (Vietnam) 1
Erlotinib DAV (Vietnam) 1
Sorafenib DAV (Vietnam) 1

Also appears on these molecule pages

Ciprofloxacin API Erlotinib API Sorafenib API

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 81 None
NPRA (MY) 1 None

Questions about Công ty Cổ Phần Dược Phẩm Reliv

Does Công ty Cổ Phần Dược Phẩm Reliv hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Công ty Cổ Phần Dược Phẩm Reliv. It does have 82 filings with 2 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
What does Công ty Cổ Phần Dược Phẩm Reliv make?
3 molecules are on record against Công ty Cổ Phần Dược Phẩm Reliv, including Ciprofloxacin, Erlotinib and Sorafenib. Each links through to that molecule's full manufacturer list.
Where does Công ty Cổ Phần Dược Phẩm Reliv file?
Filings are on record with DAV (Vietnam) and NPRA (MY), 82 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Công ty Cổ Phần Dược Phẩm Reliv comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

MSN Laboratories shares 2 molecules Hetero shares 2 molecules Cipla shares 2 molecules Alembic Pharmaceuticals shares 2 molecules Natco Pharma shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability